Superbugs could kill millions and trigger $2 trillion economic meltdown by 2050
MRSA bacteria in a petri dish. The US, UK and EU economies are on course to be among those hardest hit by antimicrobial resistance. Photograph: Fabrizio Bensch/Reuters
Tired of too many ads?
Remove Ads
Tired of too many ads?
Remove Ads
Tired of too many ads?
Remove Ads
By 2050, if the increase in antimicrobial resistance AMR ) is not stopped, superbugs could kill millions more people and cost the world economy around $2 trillion annually, according to new modelling.The Centre for Global Development, a report supported by the UK government, cautions that rising AMR rates might deplete global GDP by $1.7 trillion a year over the next 25 years.Also read: Untreatable fungal infections are now killing nearly 3.8 mn each year, WHO experts sound alarm Economies such as the US, UK, and EU are projected to suffer some of the heaviest financial blows, leading critics to slam recent cuts to foreign aid budgets as short-sighted and harmful. Fleming Fund , aimed at AMR combatThese concerns follow the UK's recent decision to scrap funding for the Fleming Fund, a programme dedicated to combating AMR in lower-income nations. Similar aid reductions have been made by the US, which slashed its overseas aid by 80%, and various European countries.According to the study's worst-case scenarios, Anthony McDonnell, the principal author, cautioned that these aid cuts could hasten resistance rates worldwide. Even nations that are now efficiently handling the threat run the danger of seeing rising infection rates and death tolls in the absence of specialised AMR measures.The modelling, which examined the economic and health burden of AMR across 122 nations, forecasts stark outcomes.The worst-case scenario is that by 2050, China's yearly GDP losses might amount to $722 billion, the US $295.7 billion, the EU $187 billion, Japan $65.7 billion, and the UK $58.6 billion.Also read: AI stuns scientists : Superbug mystery solved in 48 hours after decade long research According to data from the Institute for Health Metrics and Evaluation (IHME), the number of deaths from AMR is expected to increase by 60% by 2050, reaching 1.34 million deaths in the US and 184,000 in the UK annually.Additionally, a sharp increase in drug-resistant bacterial infections is anticipated, which will result in more hospital stays, longer treatment durations, and higher medical expenses.The cost of treating these infections is already around double that of treating non-resistant illnesses.Globally, the health costs of AMR could rise to $176 billion a year. The UK's annual health bill could surge from $900 million to $3.7 billion, and the US from $15.5 billion to nearly $57 billion.The knock-on effect would shrink workforces too: 0.8% in the UK, 0.6% in the EU, and 0.4% in the US. However, the study suggests that investing in solutions, such as developing new antibiotics and improving infection treatment, could deliver substantial economic benefits.By 2050, the US economy could grow by $156.2 billion annually and the UK by $12 billion if action is taken.IHME's Dr. Mohsen Naghavi emphasised that AMR is becoming a bigger threat. Once-treatable illnesses could turn deadly in the absence of immediate, concerted action.Also read: Fighting superbugs: New paper-based platform enables rapid antibiotic-resistance screening Policy reforms, the creation of novel medications, and increased public knowledge of the limitations of antibiotics in treating viral infections are all necessary for solutions.A representative representing the UK government reiterated their dedication to combating AMR by developing vaccines, reducing the use of antibiotics in agriculture, and supporting novel treatments. According to the administration, it is still working with other countries to stop the development of antibiotic resistance.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Deccan Herald
2 hours ago
- Deccan Herald
Trump's Golden Dome looks for alternatives to Musk's SpaceX
Washington: The Trump administration is expanding its search for partners to build the Golden Dome missile defense system, courting Project Kuiper and big defense contractors as tensions with Elon Musk threaten SpaceX's dominance in the program, according to three sources familiar with the shift marks a strategic pivot away from reliance on Musk's SpaceX, whose Starlink and Starshield satellite networks have become central to US military communications. It comes amid a deteriorating relationship between Trump and Musk, which culminated in a public falling-out on June 5. Even before the spat, officials at the Pentagon and White House had begun exploring alternatives to SpaceX, wary of over-reliance on a single partner for huge portions of the ambitious, $175 billion space-based defense shield, two of the sources said. Musk and SpaceX did not respond to requests for comment. After Reuters reported initially that SpaceX was a frontrunner to build parts of Golden Dome, Musk said on X that the company had "not tried to bid for any contract in this regard. Our strong preference would be to stay focused on taking humanity to Mars.".New Trump human resources czar distances himself from Elon to its size, track record of launching more than 9,000 of its own Starlink satellites, and experience in government procurement, SpaceX still has the inside track to assist with major portions of the Golden Dome, especially launch contracts, sources Kuiper, which has launched just 78 of a planned constellation of 3,000 low-earth orbit satellites, has been approached by the Pentagon to join the effort, signaling the administration's openness to integrating commercial tech firms into national defense infrastructure and going beyond traditional defense Bezos, Amazon's executive chairman, told Reuters in January that Kuiper would be "primarily commercial," but acknowledged "there will be defense uses for these [low-earth orbit] constellations, no doubt.".A spokesperson for Project Kuiper declined to comment for this story. The Pentagon declined to comment. The White House did not respond to requests for Dome's ambitions mirror those of Israel's Iron Dome - a homeland missile defense shield - but a larger, more complex layered defense system requires a vast network of orbiting satellites covering more territory..'Just release Epstein files as promised': Elon Musk to Donald Trump amid the search for more vendors for the satellite layers of Golden Dome, "Kuiper is a big one," a US official said. While SpaceX remains a frontrunner due to its unmatched launch capabilities, its share of the program could shrink, two of the people said. Officials have reached out to new entrants like rocket companies Stoke Space and Rocket Lab are gaining traction and will be able to bid on individual launches as the program matures, according to the US in the development of Golden Dome "each individual launch is going to get bid, and we have to actually give bids to other people," besides SpaceX, the official for is an urgent need for more satellite production. Last year Congress gave Space Force a $13 billion mandate - up from $900 million - to buy satellite-based communication services in what was widely seen as one of many efforts to stimulate private sector satellite production. Amazon's Project Kuiper, a $10 billion initiative led by former Starlink managers dismissed by Musk for slow progress, Reuters has reported, has lagged behind SpaceX in deployment. But its potential defense applications - such as communications that could aid missile tracking - have drawn renewed interest as the administration prepares to allocate the first $25 billion tranche of funding authorized under Trump's sweeping tax and spending defense giants Northrop Grumman, Lockheed Martin, and L3Harris are also in talks to support Golden Dome. L3Harris CFO Kenneth Bedingfield told Reuters in an interview the company has seen a surge in interest in its missile warning and tracking technologies, which are expected to play a key role in the meanwhile, is pursuing several efforts including a space-based interceptor, a component that would enable missile strikes from orbit, Robert Flemming, the head of the company's space business, told Reuters in an interview.."Lockheed Martin is ready to support Golden Dome for America as a proven mission partner," Robert Lightfoot, president of Lockheed Martin Space, said in a statement. Golden Dome's initial outreach this spring invited smaller, newer Silicon Valley firms seen as nimbler, more sophisticated and potentially less expensive alternatives to the big defense firms to the table - but that was before the Musk-Trump feud upended that calculus. Several with close ties to Trump aside from SpaceX, including Palantir and Anduril - were considered early frontrunners to win big pieces of the $175 billion the Musk-Trump feud has reshaped the competitive landscape. Musk recently launched the "America Party," a tech-centric, centrist political movement aimed at defeating Republicans who backed Trump's tax-and-spend launched the Golden Dome initiative just a week into his second term, pushing for rapid deployment. Space Force General Michael Guetlein, confirmed by the Senate on July 17, is set to lead the program with sweeping a previously unreported directive from Defense Secretary Pete Hegseth, Guetlein has 30 days from confirmation to build a team, 60 days to deliver an initial system design, and 120 days to present a full implementation plan, including satellite and ground station details, two people briefed on the memo said. The inclusion of commercial platforms like Kuiper raises security concerns. Its satellites would need to be hardened against cyberattacks and electronic warfare, a challenge that has plagued even SpaceX's Starlink network. In May 2024, Elon Musk said SpaceX was spending "significant resources combating Russian jamming efforts. This is a tough problem." Beyond the technical and political challenges, Golden Dome could reshape global security dynamics. A fully operational space-based missile shield may prompt adversaries to develop new offensive capabilities or accelerate the militarization of space.
Time of India
2 hours ago
- Time of India
Trump tariff pressure: AstraZeneca to move production to US, announces $50 billion manufacturing push
British pharmaceutical giant AstraZeneca on Tuesday announced plans to invest $50 billion in the United States, including the construction of a multi-billion-dollar manufacturing facility in Virginia—its largest-ever single manufacturing investment—amid rising pressure from the Trump administration's tariff push. Tired of too many ads? go ad free now The company said it expects 50% of its total revenue to come from the US by 2030, underlining its strategic shift toward the American market, AFP reported. 'Today's announcement underpins our belief in America's innovation in biopharmaceuticals,' AstraZeneca CEO Pascal Soriot said in a statement. The announcement comes as US President Donald Trump ramps up threats of new tariffs on pharmaceutical imports, which had long been exempt from his broader import levies. A White House-ordered investigation is currently underway, with duties potentially reaching as high as 200%, according to administration signals. 'For decades Americans have been reliant on foreign supply of key pharmaceutical products,' US Commerce Secretary Howard Lutnick said, AFP quoted. He added that the new tariff measures are aimed at 'ending this structural weakness' in domestic drug supply chains. The Virginia factory forms the centrepiece of AstraZeneca's expanded US operations and reflects broader trends in the industry. Other major pharmaceutical firms, many of which had avoided tariffs for the past 30 years, have also begun shifting investment and production to the US in recent months. AstraZeneca had already announced in April that it was relocating part of its European production to the US, even before the latest tariff measures gained momentum.
Time of India
3 hours ago
- Time of India
UK and ChatGPT maker OpenAI sign new strategic partnership
Britain and ChatGPT maker OpenAI have signed a new strategic partnership to expand AI security research collaboration and explore investing in UK AI infrastructure , such as data centres, the government said on Monday. "AI will be fundamental in driving the change we need to see across the country - whether that's in fixing the NHS (National Health Service), breaking down barriers to opportunity or driving economic growth," technology minister Peter Kyle said in a statement. "This can't be achieved without companies like OpenAI, who are driving this revolution forward internationally. This partnership will see more of their work taking place in the UK."
